Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Ablation Frontiers logo — Pioneering solutions for cardiac arrhythmias with innovative...

Ablation Frontiers

Pioneering solutions for cardiac arrhythmias with innovative catheter systems and advanced RF technology.

Founded 2004 Series C Total: $40.47M Biopharma, Biotechnology +4

General Information

Company Name Ablation Frontiers
Founded Year 2004
Industries Biopharma, Biotechnology, Health Care +3
Funding Stage Series C
Social

Get notified when Ablation Frontiers moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Ablation Frontiers

Ablation Frontiers is a Carlsbad, California-based medical device company founded in 2004. The company focuses on developing innovative catheter systems and advanced RF technology to assist individuals with atrial fibrillation (AF) and other cardiac arrhythmias. In 2006, they obtained CE Mark approval to market their catheter system and the GENius™ Radiofrequency (RF) Generator in the European Union for the treatment of supraventricular arrhythmias and atrioventricular node ablation. Ablation Frontiers is currently conducting a clinical trial under a United States Food and Drug Administration (FDA) investigational device exemption (IDE) to seek approval for its catheter system for the treatment of permanent/long-standing persistent/chronic AF in the United States. It's important to note that Ablation Frontiers' products are not yet approved for marketing or sales in the US. The company's last investment was a $21.80M Series C investment on 17 July 2007, with participation from notable investors such as Aberdare Ventures, Novartis Venture Fund, Versant Ventures, Hexagon Investments, affinity ventures ag, Pequot Capital, and Trellis Health Ventures. Ablation Frontiers operates within the biopharma, biotechnology, health care, health and wellness, manufacturing, and medical devices sectors.

Taxonomy: cardiac arrhythmias, catheter systems, RF technology, AF treatment, CE Mark approval, FDA clinical trial, innovation, regulatory approval, Ablation Frontiers, RF generator, chronic AF, clinical research, cardiology

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 7
Investor Investor Investor Investor Investor
•••• •••• 		17 Jul 2007
Series B •••••• 2
Investor
•••• •••• 		24 Feb 2006
Series A •••••• 1
Investor
22 Jun 2004

Ablation Frontiers Alternatives & Competitors

Ablation Frontiers vs
CardioFocus
CardioFocus

Lesion Creation at the Speed of Light

Series Unknown
65 employees
Biotechnology, Health Care
Compare Ablation Frontiers vs CardioFocus
Ablation Frontiers vs
NCONTACT SURGICAL, INC.
NCONTACT SURGICAL, INC. United States

Innovative solutions for effective, endoscopic arrhythmia treatment

Debt Financing
14 employees
Health Care, Pharmaceutical
Ablation Frontiers vs
Avenu Medical
Avenu Medical United States

Avenu Medical is a well-established medical device company dedicated to creating a paradigm shift in...

Series Unknown
10 employees
Health Care, Medical Devices

FAQ About Ablation Frontiers

Pioneering solutions for cardiac arrhythmias with innovative catheter systems and advanced RF technology.
Ablation Frontiers was founded in 2004.
Ablation Frontiers operates in the following industries: Biopharma, Biotechnology, Health Care, Health and Wellness, Manufacturing, Medical Devices.
Ablation Frontiers has completed 3 funding rounds, raising a total of $40.47M. The latest funding stage is Series C.
Top alternatives and competitors to Ablation Frontiers include CardioFocus, NCONTACT SURGICAL, INC., Avenu Medical, Endosense, CryoCor. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ablation Frontiers and CardioFocus are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Ablation Frontiers and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes